disease: 10-year results of a randomized trial plus extended field radiation therapy in early and intermediate Hodgkin (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine